ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BVC Batm Advanced Communications Ld

20.60
0.00 (0.00%)
Last Updated: 14:07:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications Ld LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.60 20.10 20.90 20.60 20.60 20.60 30,145 14:07:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Communications Services, Nec 122.83M -193k -0.0004 -515.00 89.82M
Batm Advanced Communications Ld is listed in the Communications Services sector of the London Stock Exchange with ticker BVC. The last closing price for Batm Advanced Communicat... was 20.60p. Over the last year, Batm Advanced Communicat... shares have traded in a share price range of 15.75p to 30.55p.

Batm Advanced Communicat... currently has 436,039,124 shares in issue. The market capitalisation of Batm Advanced Communicat... is £89.82 million. Batm Advanced Communicat... has a price to earnings ratio (PE ratio) of -515.00.

Batm Advanced Communicat... Share Discussion Threads

Showing 45351 to 45369 of 47275 messages
Chat Pages: Latest  1819  1818  1817  1816  1815  1814  1813  1812  1811  1810  1809  1808  Older
DateSubjectAuthorDiscuss
31/12/2022
11:56
We will see but unfortunately the evidence is that Batm went for anything they could when people were scrabbling for basic test kits and got very little..even with generous introductions! Maybe they do have a product with a competitive advantage now..but its rather difficult to know with the progress in testing that has been made by a huge field of runners and riders. I doubt they are that ahead of the competition. If Adaltis or ADOR has a quick efficient system to identify different strains then now would be the time to bring it forward as it seems the biggest concern is that China may well be experiencing a new strain that could be spread to other countries that could undermine vaccination efforts. Any ideas if this is where they are ?
kooba
31/12/2022
11:51
BATM did come late to the testing party but are perfectly placed now with their less invasive option.
resistance1
31/12/2022
11:36
I completely agree that BATM were never anything approaching a real 'covid testing' share. That partial-reputation was, I thought, connected primarily to the one-off ventilator windfall contract, rather than any real effort to compete in the broader testing kit space. Nor, I've always assumed, did Zvi and the Company have any interest in being associated with the latter in the first place, but rather to see where BATM might be able to offer genuinely unique or at least cutting edge solutions, which I think this 'Southeast Asian' contract involves.
echoridge
31/12/2022
09:21
Problem is with Batm as a covid stock is they should have been a huge beneficiary during an extended pandemic as an existing pathogen testing company but weren't really..a few small Italian contracts and a small one with Russia i seem to remember but nothing huge ,the biggest gain was all rather odd being in ventilators , white labelled or otherwise that they had no previous experience in. If they could secure something meaningful now would be great but the field and capacity to produce bog standard tests is a different place than March 2020. Here's hoping though I'd love to dot a few out on a Abingdon Novacyt type bounce both up 50% + over last 5 days.
kooba
31/12/2022
09:09
With now the UK and surely the EU falling into line on testing, and seeing some testing companies share prices jump 41% by Fridays half day trading close, I think we are due a significant bounce on Tuesdays open.
resistance1
31/12/2022
08:44
According to a report by Bloomberg News, about 248 million people, or nearly 18% of the population of China contracted covid in the first 20 days of December.
wizzkid211
30/12/2022
11:50
Well increased testing certainly won’t hurt the share price. Let’s see what the EU does re testing on inbound flights from China. Will mean increased urgency for the Far East order to come through I would have thought.
resistance1
30/12/2022
11:11
This one is not hot so must not be seen as a covid stock. I thought covid testing was BATM's big asset and was part of the reason posters explained the fall in the share price. I'm relying on Simon Thompson to tip it in January and get suckers to buy it so I can sell at 30+p. I can dream
car1pet
30/12/2022
10:46
Looks like covid stocks are hot again, NOVACYT up 35% today
wizzkid211
29/12/2022
21:44
With Italy requiring Covid tests from Chines arrivals a reminder of the broader field here with respect to accurate more informative testing.
Testing is likely going to stay around due to the ever changing variables with the way the footprint alters.

Further to the Group's announcement of 11 March 2021, BATM is pleased to confirm that it has commenced supplying its test that uses self-collected saliva samples to diagnose COVID-19 using the RT-PCR technique.



The initial customers are public health authorities in Italy that are using the tests in schools and elderly care homes where there is a particular benefit for having a non-invasive sample collection method without compromising diagnostic accuracy. The provision of the tests is due to be expanded to several other groups as production increases. The test is also due to be used by the Italian Olympic Committee for the Olympic Games that are scheduled to commence in Japan in July. This follows the Italian Olympic Committee selecting two labs to provide testing for the tournament, one of which uses only the Group's antigen RT-PCR kits for COVID-19 testing, including the latest saliva-based test.



The test involves the individual spitting into a collector tube rather than deep swabbing via the nose (nasopharyngeal swab) or back of the throat (oropharyngeal swab). It is based on the Group's antigen RT-PCR kit that has five (4+1) gene discovery capability, which enables detection even with a very low viral load and has 100% accuracy for specificity and sensitivity. The test can be administered without the need for trained healthcare workers in full body personal protective equipment, offering advantages in terms of speed of sample collection as well as lab processing and being more cost effective than the RT-PCR process for standard swab-based tests.



The Group is producing the test at its Adaltis facility in Rome, Italy, which continues to increase manufacturing output. More information can be found here.

fse
29/12/2022
20:24
Highly unlikely with China imo...more likely someone not wanting to be dependent on China one of the worlds largest test producers like Taiwan , Vietnam ?
kooba
29/12/2022
20:04
Who said it the order was with China? Certainly not the Company
echoridge
29/12/2022
19:38
My reverse logic with the Chinese contract is that they can't afford it, they have many others things they need to put right, surely they would have signed it by now, hope I'm wrong!
gbenson1
29/12/2022
17:44
Some "covid" counters had a decent day as testing regimes return ..Avacta Abingdon ..maybe being seen as a covid beneficiary might not be the worst for now. Could mean if there is a rush for tests that any contract dragging its feet gets signed off...we can but hope!
kooba
29/12/2022
17:43
I had to filter Letsdothis. Account must have been hacked.
resistance1
29/12/2022
17:13
where are you going ? over the cuckoos nest I suspect.
fse
29/12/2022
15:09
Looks like South West Airlines could use some help from Edgility..... kind of gets the point across that systems in so many large companies are overdue a complete upgrade and re think... lots of potential clients around just have to get the purse strings eased....
fse
29/12/2022
10:57
Israeli Tech Exits Crash to One-Fifth of 2021 Level, PwC Says
Total deal value fell from $82.4 billion to $16.9 billion

The value of initial public offerings and mergers and acquisitions in Israel’s tech industry this year fell to one-fifth of 2021 levels as rising interest rates and economic uncertainty forced “a reckoning,” according to a report by PricewaterhouseCoopers LLP.

There were 72 deals raising a total of $16.9 billion in 2022, down from 171 deals that brought $82.4 billion the previous year, with most of of transactions taking place in the first half, PwC Israel analyst Yaron Weizenbluth wrote in the report published Wednesday.

dds14
29/12/2022
09:32
Apparently we won't test Chinese arrivals. Unbelievable. 50% entering Italy have covid. We will have another wave soon.
car1pet
Chat Pages: Latest  1819  1818  1817  1816  1815  1814  1813  1812  1811  1810  1809  1808  Older

Your Recent History

Delayed Upgrade Clock